CHINA PHARMA HOLDINGS, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $70.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2026-04-01
- CHINA PHARMA HOLDINGS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2025 was $70.00K.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|
| 2025-12-31 | $70.00K 10-K · filed 2026-04-01 | |
| 2017-09-30 | -$95.55K 10-Q · filed 2017-11-14 | |
| 2016-09-30 | $1.42M 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |